Stress and Mental Ill-health in the Workplace: Evaluation of an Intervention for the Prevention of Sick Leave

September 5, 2021 updated by: Gunnar Bergström, Karolinska Institutet

Preventing Sickness Absenteeism Among Employees With Common Mental Disorders and Stress-related Symptoms: a Cluster Randomized Trial of a Problem-solving Based Intervention Versus Care-as-usual Conducted at the Occupational Health Services

Purpose

Common mental disorders (CMD:s) are the leading cause of sick-leave spells in Sweden, resulting in suffering for the individual and financial costs for the employer as well as for society at large. Studies on interventions that address stress and mental ill-health and that focus on sick leave and return to work (RTW) show little or no effect of commonly used methods such as medication or psychological approaches. Furthermore, these interventions often focus on the individual's symptoms without considering their work situation. The occupational health services (OHS) has knowledge of the employee's work environment and can offer treatment facilitating the employee's RTW and improving the employee's work ability while taking into account both the individual and the work situation. The intervention in the current study will be performed at the OHS.

The study aim is two-fold: first, an intervention that addresses both individual and workplace related aspects among employees with work-related CMD:s and/or stress related symptoms will be evaluated. In particular, the treatment's cost-effectiveness and impact on sick leave and mental health will be studied. Secondly, the concerned OHS staff's adherence to the intended treatment and associations with the outcome of the intervention will be assessed.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 14141
        • Karolinska Institutet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 63 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The employee suffers from stress related symptoms or work-related common mental disorders.
  • The employee is either not on sick leave or is on sick leave for a maximum of 3 consecutive months (full or part time).
  • The employee understands both written and spoken Swedish.
  • The employees nearest supervisor should be aware of the employees visit(s) at the OHS (to avoid differential selection into the experimental and the control condition)

Exclusion Criteria:

  • Bullying
  • Pregnancy
  • Post traumatic stress-disorder
  • Severe mental disorders (e.g. psychosis)
  • Any co-morbidity that may substantially affect the employee's ability to work and/or quality of life.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Problem-solving based intervention
Problem-solving based intervention with a participative approach. During the intervention a systematic assessment of the match between the employee and the work environment is considered. The intervention applies a participatory approach where the supervisor and the employee are guided by the OHS consultant and encouraged to actively take part in problem solving concerning the work situation. The intervention consists of three meetings, one between the OHS consultant and a representative for the employer (usually the nearest supervisor), one between the consultant and the employee and then a third meeting where all three parties participate.
The intervention comprises both the employee and the employer, and follows a clear structure comprising problem solving, stepwise activation and relapse prevention. It includes three meetings at the OHS with additional follow-ups.
Active Comparator: Treatment as usual
The control intervention consists of the usual interventions given at the participating OHS. These interventions are also work-directed and usually also include participation of both the employee and the supervisor. However, structured problem solving methods and the systematic consideration of the match between the employee and the job situation are not applied. The content of the control condition will vary between different occupational health service units.
Study participants that are randomized into the control group will receive the usual care given at the OHS. This intervention will differ due to differences between the OHS units.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in total registered sickness absenteeism during the 12 month follow-up period.
Time Frame: At baseline and 12 months after baseline.

(1) Total sick leave in days, register data (sickness benefit and disability pension). Sickness benefit and disability pension will also be analyzed separately.

The analyses will be repeated for outcomes on registered sick leave at a three-years follow-up

At baseline and 12 months after baseline.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in self-reported sickness absenteeism during the 12 months follow-up period
Time Frame: At baseline and during monthly follow-ups for a period of 12 months

Self-report data obtained every four weeks during the 12-months follow-up period. These data also include short spells of sick leave.

Possible interaction effects on the primary and secondary outcomes for (1) gender x treatment (intervention) and (2) sick leave status (sick leave/no sick leave) x treatment will be checked for and if statistically significant subgroup analyses will be considered.

At baseline and during monthly follow-ups for a period of 12 months
The prevalence of no sick leave, part-time sick leave and full-time sick leave during the 12 months follow-up period following baseline
Time Frame: Twelve months after baseline
Change from baseline in self-reported data (no sick leave, 25%, 50%, 75% or 100% sick leave) obtained every fourth week during a follow-up period of 12 months
Twelve months after baseline
Among those sick listed at baseline: Time to full Return to Work (RTW) during a follow-up period of 12 months
Time Frame: At baseline and during monthly follow-ups for a period of 12 months
RTW will be calculated from the study inclusion date until the individual returns in ordinary hours of work during an uninterrupted period of at least four weeks. Self-reported data obtained every fourth week during a follow-up period of 12 months.
At baseline and during monthly follow-ups for a period of 12 months
Among those sick listed at baseline: Time to Return to Work (RTW) during a follow-up period of 12 months
Time Frame: At baseline and during monthly follow-ups for a period of 12 months
RTW will be calculated from the study inclusion date until the individual returns to work in any increased level (25%, 50%, 75% or 100%). Self-reported data obtained every fourth week during a follow-up period of 12 months.
At baseline and during monthly follow-ups for a period of 12 months
Work performance impairment due to health problems
Time Frame: Will be assessed at baseline and once a month during a 12-month follow-up period
Change from baseline in work performance as assessed by a question based on one item from the Work Productivity Activity Impairment - General Health Questionnaire (response format from 0-10).
Will be assessed at baseline and once a month during a 12-month follow-up period
Work performance impairment due to problems in working environment
Time Frame: Will be assessed at baseline and every other month (eighth weeks intervals) during a 12-month follow-up period
Change from baseline in work performance as assessed by a question based on one item from the Work Productivity Activity Impairment - General Health Questionnaire (response format from 0-10).
Will be assessed at baseline and every other month (eighth weeks intervals) during a 12-month follow-up period
Cost-effectiveness of the intervention compared to treatment as usual.
Time Frame: At 12 months after baseline
The cost-effectiveness of the intervention will be calculated with regard to production loss (sick leave and performance while at work).
At 12 months after baseline
Work satisfaction
Time Frame: Will be assessed at baseline and after 6 and 12 months.
Change from baseline in self-reported work satisfaction will be assessed by a single item (response format from 0-10).
Will be assessed at baseline and after 6 and 12 months.
Work ability index (WAI)
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
Change from baseline in self-reported work ability as assessed by two items from WAI (response format from 1-5). The items relate to perceived capacity to work relative to the physical (1 item) and mental (1 item) demands of the work.
Will be assessed at baseline and after 6 and 12-months of study inclusion.
Sickness presenteeism
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
Change from baseline in sickness presenteeism is assessed with a single question (response format from 1-4).
Will be assessed at baseline and after 6 and 12-months of study inclusion.
The Institute of Stress Medicine's instrument for self-rating of stress-related Exhaustion Disorder (s-ED)
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
Change from baseline in self-reported exhaustion on the s-UMS (two yes/no items and one item with a response format from 0-2.
Will be assessed at baseline and after 6 and 12-months of study inclusion.
Maslach Burnout Inventory - General Survey, Exhaustion-scale
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
Change from baseline in self-reported exhaustion as assessed by the MBI-GS's exhaustion scale (response format from 0 to 6).
Will be assessed at baseline and after 6 and 12-months of study inclusion.
Hospital Anxiety and Depression Scale
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
Change from baseline in self-reported mental health as assessed by the Hospital Anxiety and Depression Scale (response format from 0-3).
Will be assessed at baseline and after 6 and 12-months of study inclusion.
Self-perceived health
Time Frame: Will be assessed at baseline and after 6 and 12-months of study inclusion.
Change from baseline in self-perceived health will be assessed with a single question (response format from 1-5).
Will be assessed at baseline and after 6 and 12-months of study inclusion.
European Quality of Life - 5 Dimensions questionnaire (EQ-5D)
Time Frame: Will be measured at baseline and after 6 and 12-months of study inclusion.
Change from baseline in self-assessed health as assessed by EQ-5D (response format from 1-3).
Will be measured at baseline and after 6 and 12-months of study inclusion.
Self-reported stress
Time Frame: At baseline and every other month (eighth weeks intervals) during a follow-up period of 12 months
Change from baseline in self-reported stress as assessed by a single item (response format from 1-5).
At baseline and every other month (eighth weeks intervals) during a follow-up period of 12 months
Karolinska Sleep Questionnaire, Insomnia sub-scale
Time Frame: Will be measured at baseline and after 6 and 12-months of study inclusion.
Change from baseline in self-assessed sleeping problems as assessed by the Insomnia subscale of the Karolinska Sleep Questionnaire (response format from 1-6).
Will be measured at baseline and after 6 and 12-months of study inclusion.
Demand-control-support model. Prognostic variable.
Time Frame: Baseline and at 6 and 12 months of study inclusion
Change from Baseline at 6 and 12 months (response format from 1-4).
Baseline and at 6 and 12 months of study inclusion
Other work related variables such as ongoing conflicts with the superior, perceived loss of control over work tasks and conflicts between the employee´s values and how the work actually is done. Prognostic variables.
Time Frame: Baseline and at 6 months after study inclusion
Change from baseline at 6 and 12 months after baseline (Likert-type scales with 3 to 5 response options).
Baseline and at 6 months after study inclusion
Physical activity. Prognostic variable.
Time Frame: At 6 and 12 months after intervention
Physical activity will be assessed by a single item. Response options: 0 minutes, less than 30 minutes, 30-60 minutes, 60-90 minutes, 90-120 minutes or more than 120 minutes.
At 6 and 12 months after intervention
Change in work conditions. Prognostic variable.
Time Frame: At 6 and 12 months after intervention
Possible changes to the participant's work conditions will be asked by a single item with 12 choices.
At 6 and 12 months after intervention
Change in the organization. Prognostic variable.
Time Frame: At 6 and 12 months after intervention
Possible changes in the organization over the past six months are assessed with four response options.
At 6 and 12 months after intervention
Participants' satisfaction and experiences with the intervention or treatment as usual will be assessed at 6 months after completed intervention by eleven items (response format from 0-10 or yes/no/do not know). Process evaluation data.
Time Frame: Will be assessed 6 months after intervention.
These items referred to aspects such as quality of the communication with the OHS personnel, relevance of the intervention, perceived problem-solving skills learned during the intervention, planned adjustments at work, agreement with the supervisor, the implementation of planned adjustments, if follow-up contacts with the OHS have been undertaken and questions regarding treatment satisfaction).
Will be assessed 6 months after intervention.
OHS staff's adherence to the intervention (process evaluation data)
Time Frame: Assessed at the end of the 12-18 months long recruitment period
Self-reported data, single items.
Assessed at the end of the 12-18 months long recruitment period
Implementation of the intervention and entire research project at the OHS units (process evaluation data)
Time Frame: Assessed at the end of the 12-18 months long recruitment period
Self-report data, single items and focus group interviews
Assessed at the end of the 12-18 months long recruitment period
Three years follow-up: Change from Baseline in registered sickness absenteeism during a 3-year follow-up period
Time Frame: At baseline and 3 years after baseline.

Total sick leave in days, register data (sickness benefit and disability pension).

The analyses will be conducted in accordance with the 12-month follow-up.

At baseline and 3 years after baseline.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gunnar Bergström, PhD, Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2015

Primary Completion (Actual)

May 30, 2018

Study Completion (Actual)

May 30, 2020

Study Registration Dates

First Submitted

September 21, 2015

First Submitted That Met QC Criteria

September 28, 2015

First Posted (Estimate)

September 30, 2015

Study Record Updates

Last Update Posted (Actual)

September 13, 2021

Last Update Submitted That Met QC Criteria

September 5, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Common Mental Disorders and/or Stress Related Symptoms

Clinical Trials on Problem-solving based intervention

3
Subscribe